Dietary modifications are among the most effective interventions: Eat smaller, more frequent meals rather than large portions, which can overwhelm your slowed digestive system Choose bland, easily digestible foods during the first few days, such as crackers, toast, rice, bananas, and applesauce Avoid high-fat, greasy, or spicy foods that may exacerbate nausea Limit foods with strong odors if you are experiencing nausea Eat slowly and chew thoroughly to aid digestion Stop eating when you feel comfortably satisfied, as overeating can worsen gastrointestinal discomfort Hydration strategies are critical, especially if experiencing nausea, vomiting, or diarrhea: Sip water, clear broths, or electrolyte solutions throughout the day Avoid large volumes of liquid at once, which can increase nausea Consider ginger tea or peppermint tea, which may help settle the stomach Limit caffeine and alcohol, as these can worsen dehydration and gastrointestinal symptoms Timing and lifestyle adjustments can also help: Administer your injection at a consistent time each week, preferably when you can rest if needed Some patients anecdotally report that injecting in the evening may reduce daytime nausea, though this varies by individual Avoid lying down immediately after eating, which can worsen reflux or nausea Engage in light physical activity, such as short walks, which may help with digestion and reduce bloating Pharmacological support may be appropriate in some cases
A baseline thyroid ultrasound is recommended for all Hashimoto's patients starting GLP-1 medications
A same-day switch, which involves starting semaglutide on the next scheduled tirzepatide dose
Record batch information within institutional tracking systems and apply established contamination control procedures
Zepbound Data as Reported by Lilly The manufacturers language on the weight loss indication reads thus: Zepbound is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. At 72 weeks, patients taking Zepbound 15mg lost an average of 20.9% of their body weight
